IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
LEARN MORE
IJPC on Facebook
 
Sign On
  • Home
  • About
    • The Journal
    • Editor-In-Chief
    • Editorial Calendar
    • Submissions
    • Advertising
    • Permissions & Reprints
    • Privacy Policy
  • Subscriptions
    • Subscribe
    • Renew
    • Prices
    • Free Sample
  • Store
    • View Shopping Cart
    • Back Issues
    • Articles
    • Library Archives
    • Compounding Theme Archives
    • Other Products
  • Resources
    • Supplemental Content and Errata
    • Training and Education
    • IJPC-PCAB SOP Matrix
    • USP GAP Analysis
    • Compounders' Network List
    • Patient Information
    • Videos
    • Compounders' Resource Directory
  • Account
  • Contact US

Library CD
Volume 7, 2003 CD
Six back issues from 2003 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.
Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 7 No. 1 January/February 2003 Terrorism
Vol. 7 No. 2 March/April 2003 Terrorism
Vol. 7 No. 3 May/June 2003 Diabetes and Wound Care
Vol. 7 No. 4 July/August 2003 After the Women's Health Initiative Trial
Vol. 7 No. 5 September/October 2003 After the Women's Health Initiative Trial
Vol. 7 No. 6 November/December 2003 Compounding for Investigational Studies

Volume 7, 2003 CD ARTICLES

Volume 7, 2003 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Compounding for the Effects of Weapons of Mass Destruction Vol. 7 No. 1 10
Diabetes Mellitus: Pathophysiology and Complications Vol. 7 No. 1 17
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vol. 7 No. 1 21
Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD. Vol. 7 No. 1 24
Equine Cushing’s Syndrome Vol. 7 No. 1 27
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 2 Vol. 7 No. 1 32
Packaging Choices for Compounded Materials Vol. 7 No. 1 37
Technology Spotlight: Barrier Isolators Vol. 7 No. 1 42
Determining the Availability of a Commercial Drug Vol. 7 No. 1 44
Calculations Vol. 7 No. 1 46
Featured Excipient: Flavor Enhancing Agents Vol. 7 No. 1 48
Basics of Compounding for Terrorist Attacks, Part 1 Vol. 7 No. 1 51
Amoxicillin 125-mg/5-mL and 250-mg/5-mL Suspensions Vol. 7 No. 1 55
Atropine 1-mg Gelatin Troches Vol. 7 No. 1 56
Atropine Sulfate 0.1% for Inhalation Vol. 7 No. 1 57
Atropine Sulfate 0.5-mg/mL Injection Vol. 7 No. 1 58
Gentamicin Sulfate 40-mg/mL Injection Vol. 7 No. 1 59
Levofloxacin 250-mg/5mL Oral Liquid Vol. 7 No. 1 60
Ofloxacin 250-mg/5-mL Oral Liquid Vol. 7 No. 1 60
Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid Vol. 7 No. 1 61
Ribavirin 200-mg Capsules Vol. 7 No. 1 62
Sodium Hypochlorite Disinfectant Solutions Vol. 7 No. 1 63
Vancomycin HCl 50-mg/mL Oral Solution Vol. 7 No. 1 64
Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 7 No. 1 65
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes Vol. 7 No. 1 68
Use of Cysteine Hydrochloride Injection to Increase the Solubility of Calcium and Phosphates in FreAmine III-Containing Parenteral Nutrition Solutions Vol. 7 No. 1 71
Wish You Were Here: Deutsche Apotheken Museum (German Museum of Pharmacy) Vol. 7 No. 1 78
Postcription: Future Trends in High Technology Pharmaceutical Compounding Vol. 7 No. 1 80
Book and Literature Reviews Vol. 7 No. 2 84
Legal & Ethical Issues for Pharmacy Websites Vol. 7 No. 2 88
Panel Discussion: Prohormones Vol. 7 No. 2 94
Profile of a Practice: Building a Compounding Pharmacy Practice from the Ground Up: Prescription Compounding Solutions, Medford, Oregon Vol. 7 No. 2 101
Veterinary Transdermal Medications: A to Z Vol. 7 No. 2 106
Autoclaves for the Sterilization of Compounded Parenteral Products Vol. 7 No. 2 114
Barcode System and Computerized Balance Speed Compounding and Enhance Accuracy Vol. 7 No. 2 118
Technology Spotlight: Electronic Balances with Printer and Draft Shield Vol. 7 No. 2 120
Accuracy of Small-Volume Containers Vol. 7 No. 2 124
Autoclave Efficiency Validation Vol. 7 No. 2 126
Calculations Vol. 7 No. 2 128
Basics of Compounding for Terrorist Attacks, Part 2 Vol. 7 No. 2 129
Amoxicillin 250-mg Troches Vol. 7 No. 2 131
Amoxicillin 125-mg Suppositories Vol. 7 No. 2 131
Chloramphenicol 250-mg Capsules Vol. 7 No. 2 131
Chloramphenicol 150-mg/5-mL Suspension Vol. 7 No. 2 131
Cidofovir Suppositories Vol. 7 No. 2 131
Ciprofloxacin Oral Suspension Vol. 7 No. 2 131
Clindamycin HCl 150-mg Capsules Vol. 7 No. 2 132
Clindamycin Phosphate 150-mg Capsules Vol. 7 No. 2 132
Clindamycin 10-mg/mL Oral Suspension Vol. 7 No. 2 132
Doxycycline HCl 100-mg Capsules Vol. 7 No. 2 132
Erythromycin 200-mg Troches Vol. 7 No. 2 132
Erythromycin 250-mg Suppositories Vol. 7 No. 2 132
Penicillin G Potassium 20,000,000-units Injection Vol. 7 No. 2 132
Penicillin G Potassium 1,000,000-unit Injection Vol. 7 No. 2 132
Ribavirin 33-mg/mL Injection Vol. 7 No. 2 132
Rifampin 10-mg/mL Oral Suspension Vol. 7 No. 2 132
Rifampin 150-mg Capsules Vol. 7 No. 2 132
Rifampin 3-mg/mL Intravenous Infusion Vol. 7 No. 2 132
Streptomycin Sulfate 400-mg/mL Injection Vol. 7 No. 2 132
Tetracycline 125-mg/5-mL Syrup Vol. 7 No. 2 132
Tetracycline HCl 20-mg/mL Intravenous Injection Vol. 7 No. 2 132
Tetracycline HCl 250-mg Capsules Vol. 7 No. 2 132
Tetracycline HCl 250-mg Suppositories Vol. 7 No. 2 133
Vancomycin HCl 250-mg Capsules Vol. 7 No. 2 133
Albuterol Sulfate 0.5% Inhalation Solution Vol. 7 No. 2 133
Dimercaptosuccinic Acid 250-mg Capsules Vol. 7 No. 2 133
Sodium Thiosulfate-Sodium Nitrate Solution Vol. 7 No. 2 133
Potassium Iodide Saturated Solution Vol. 7 No. 2 133
Lorazepam 2-mg Gelatin Troches Vol. 7 No. 2 134
Lorazepam 2-mg Polyethlene Glycol Troches Vol. 7 No. 2 134
Oral Liquid Suspending Vehicle Vol. 7 No. 2 134
Diazepam 5-mg/mL Injection Vol. 7 No. 2 135
Dimercaprol 100-mg/mL Injection USP Vol. 7 No. 2 136
Dimercaptopropanesulfonate Sodium 50-mg/mL Injection Vol. 7 No. 2 137
Lorazepam 2-mg Sublingual Tablets Vol. 7 No. 2 138
Mafenide Acetate 85 mg/g Cream USP Vol. 7 No. 2 139
Pralidoxime Chloride 50-mg/mL Injection Vol. 7 No. 2 140
Silver Sulfadiazine 1% Cream Vol. 7 No. 2 141
Sodium Bicarbonate 8.4% Injection USP Vol. 7 No. 2 142
Sodium Nitrite 3% Injection USP Vol. 7 No. 2 143
Sodium Thiosulfate 25% Injection USP Vol. 7 No. 2 144
Featured Excipient: Plasticizers Vol. 7 No. 2 145
Stability of Clindamycin Phosphate in AutoDose Infusion System Bags Vol. 7 No. 2 149
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 2 152
Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis Vol. 7 No. 2 155
PostScription: Sterile Product Admixture Preparation Vol. 7 No. 2 160
Book & Literature Reviews Vol. 7 No. 3 164
Five Compounds for Treating Diabetes-Related Conditions Vol. 7 No. 3 170
Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO Vol. 7 No. 3 171
Sildenafil 25-mg Troches Vol. 7 No. 3 171
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection Vol. 7 No. 3 171
Misoprostol 0.0024% and Phenytoin 5% Diabetic Ulcer Cream Vol. 7 No. 3 171
Nifedipine 100- mg/mL in PLO Vol. 7 No. 3 171
Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer Vol. 7 No. 3 176
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Vol. 7 No. 3 180
ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Vol. 7 No. 3 183
Ketoprofen 10% in PLO Vol. 7 No. 3 183
Methimazole 5 mg/0.1 mL in PLO (Vet) Vol. 7 No. 3 183
Wish You Were Here: The Pearson Museum, Springfield, Illinois Vol. 7 No. 3 184
Treating Canine Hepatic Disease Vol. 7 No. 3 188
Incubators Vol. 7 No. 3 193
Further Clarification of HIPAA Regulations Vol. 7 No. 3 195
Software for the Compounding Pharmacist: An Update Vol. 7 No. 3 197
Technology Spotlight: Tube Sealers Vol. 7 No. 3 206
Accuracy of Graduated Cylinders Vol. 7 No. 3 208
Calculations Vol. 7 No. 3 212
Product Containment in the Compounding Laboratory Vol. 7 No. 3 213
Dexamethasone Phosphate 0.05% Ophthalmic Ointment Vol. 7 No. 3 215
Dexamethasone Phosphate 0.1% Topical Cream Vol. 7 No. 3 216
Dimenhydrinate 5-mg/mL Oral Liquid Vol. 7 No. 3 217
Epinephrine Bitartrate 2% Ophthalmic Solution Vol. 7 No. 3 218
Ergotamine Tartrate 2-mg Sublingual Tablets Vol. 7 No. 3 219
Hyoscyamine Sulfate 0.125-mg and Phenobarbital 15-mg/mL Oral Drops Vol. 7 No. 3 220
Methadone HCl 5-mg/mL Injection Vol. 7 No. 3 221
Minocycline 10-mg/mL Oral Liquid Vol. 7 No. 3 222
Phenytoin 6-mg/mL Oral Liquid Vol. 7 No. 3 223
Tetracycline HCl 2.2-mg/mL Topical Solution Vol. 7 No. 3 224
Quality-Control Analytical Methods: Principles of pH Vol. 7 No. 3 225
Standard Operating Procedure: Incubator Temperature Monitoring Vol. 7 No. 3 228
Stability of Amikacin Sulfate in AutoDose Infusion System Bags Vol. 7 No. 3 230
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Vol. 7 No. 3 233
PostScription: Too Many Compounders? Vol. 7 No. 3 240
Book Reviews Vol. 7 No. 4 244
Literature Review Vol. 7 No. 4 246
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Vol. 7 No. 4 250
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT Vol. 7 No. 4 258
Sensitization Therapy for Warts Vol. 7 No. 4 266
Dinitrochlorobenzene 0.5% to 2.0% in Acetone Vol. 7 No. 4 270
Dinitrochlorobenzene 0.1% to 1 % in Hydrophilic Petrolatum Vol. 7 No. 4 270
Diphenylcyclopropenone 0.01% to 0.1% in Acetone Vol. 7 No. 4 270
Squaric Acid Dibutyl Ester 0.03% to 3.0 in Acetone Vol. 7 No. 4 270
Cantharidine 0.7% Topical Vol. 7 No. 4 270
Fluorouracil 5% Gel Vol. 7 No. 4 270
Podophyllum 25% in Compound Tincture of Benzoin Vol. 7 No. 4 270
Podophyllum 1% and Salicylic Acid 3% in Flexible Collodion Vol. 7 No. 4 270
Salicylic Acid 40% Ointment Vol. 7 No. 4 270
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Vol. 7 No. 4 272
Rhus Tox Solution 2X Vol. 7 No. 4 272
Rhus Tox Solution 3X Vol. 7 No. 4 272
Rhus Tox Solution 4X Vol. 7 No. 4 272
Rhus Tox Solution 5X Vol. 7 No. 4 272
Rhus Tox Solution 6X Vol. 7 No. 4 272
Rhus Tox Solution 7X Vol. 7 No. 4 272
Rhus Tox Solution 8X Vol. 7 No. 4 272
Rhus Tox Solution 9X Vol. 7 No. 4 272
Rhus Tox Solution 10X Vol. 7 No. 4 272
Rhus Tox Solution 11X Vol. 7 No. 4 272
Rhus Tox Solution 12X Vol. 7 No. 4 272
Rhus Tox 6X/12X Solution Vol. 7 No. 4 272
HIPAA Privacy and Security for Providers: The Basics Vol. 7 No. 4 277
Containment of Hazardous Particulates in the Compounding Pharmacy Vol. 7 No. 4 281
Technology Spotlight: A USP-Grade Water System Vol. 7 No. 4 286
Basics of Compounding for Raynaud's Disease Vol. 7 No. 4 288
Nifedipine in PLO Gel Vol. 7 No. 4 291
Nitroglycerin 0.2% Ointment Vol. 7 No. 4 291
Coenzyme Q10 100-mg-in-Oil Capsules Vol. 7 No. 4 291
Zinc, Magnesium, Caldium and Vitamin D3 Oral Liquid Vol. 7 No. 4 291
How to Handle a Product Recall Vol. 7 No. 4 292
Calculations Vol. 7 No. 4 294
Brompheniramine Maleate 2-mg/5-mL Oral Liquid Vol. 7 No. 4 295
Chlorpheniramine Maleate 10-mg/mL Injection Vol. 7 No. 4 296
Chlorpromazine HCl 30-mg/mL Oral Concentrate Vol. 7 No. 4 297
Desonide 0.05% Otic Liquid Vol. 7 No. 4 298
Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection Vol. 7 No. 4 299
Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection Vol. 7 No. 4 300
Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection Vol. 7 No. 4 301
Methocarbamol 400-mg and Aspirin 325-mg Capsules Vol. 7 No. 4 302
Perphenazine 4-mg and Amitriptyline HCl 10-mg capsules Vol. 7 No. 4 303
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Vol. 7 No. 4 304
Quality-Control Analytical Methods: Viscosity Measurements Vol. 7 No. 4 305
Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 4 310
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Vol. 7 No. 4 313
Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics? Vol. 7 No. 4 320
Book and Literature Reviews Vol. 7 No. 5 324
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Vol. 7 No. 5 330
Patient Handout - Hormone Replacement Therapy Vol. 7 No. 5 339
The Role of the Pharmacist in Diabetes Care Vol. 7 No. 5 341
Understanding Feline Hyperthyroidism Vol. 7 No. 5 345
Profile of a Practice: Don West, RPh, Lloyd Center Pharmacy, Portland, Oregon Vol. 7 No. 5 350
Vancomycin Pluronic Gel Vol. 7 No. 5 354
Sterile Vancomycin Pluronic Gel for Implantation in the Chest-Wall Cavity to Treat Resistant Pneumococcus Vol. 7 No. 5 354
NDC Numbers: A New Approach Vol. 7 No. 5 358
Application of USP-NF Standards to Pharmacy Compounding Vol. 7 No. 5 361
Technology Spotlight: Respiratory Vial Sealers Vol. 7 No. 5 364
Basics of Compounding for Pediculosis Vol. 7 No. 5 366
Malathion 0.5% Topical Lotion Vol. 7 No. 5 368
Ivermectin 1% Crème Rinse Vol. 7 No. 5 368
Ivermectin 1% Lotion Vol. 7 No. 5 369
Head Lice Repellant Spray Vol. 7 No. 5 369
Standard Operating Procedure: Incubator Cleaning Vol. 7 No. 5 370
Calculations Vol. 7 No. 5 372
Chloramphenicol 1% Topical Ointment Vol. 7 No. 5 373
Guanethidine Monosulfate 10-mg and Hydrochlorothiazide 25-mg Capsules Vol. 7 No. 5 374
Indomethacin 50-mg Suppositories Vol. 7 No. 5 375
Isoniazid 10-mg/mL Oral Solution Vol. 7 No. 5 376
Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules Vol. 7 No. 5 377
Perphenazine 5-mg/mL Injection Vol. 7 No. 5 378
Phenylbutazone 100-mg Capsules Vol. 7 No. 5 379
Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules Vol. 7 No. 5 380
Thioridazine HCl 100-mg/mL Concentrated Solution Vol. 7 No. 5 381
Ursodiol 150-mg Capsules Vol. 7 No. 5 382
Quality-Control Analytical Methods: Refractometry Vol. 7 No. 5 383
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Vol. 7 No. 5 386
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Vol. 7 No. 5 389
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Vol. 7 No. 5 394
Postcriptions: Compounding Paradox: Taught Less and Practiced More Vol. 7 No. 5 399
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices Vol. 7 No. 5 401
PreScription: Take Care with Terminology for Altered- and Slow-release Formulations Vol. 7 No. 6 418
Book & Literature Reviews Vol. 7 No. 6 420
Sore Nipples in Breastfeeding Mothers: Causes and Treatments Vol. 7 No. 6 426
Mupirocin 1%, Betamethasone 0.05%, and Miconazole 2% Nipple Ointment Vol. 7 No. 6 430
Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 0.25% Nipple Ointment Vol. 7 No. 6 430
Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 2.5% Nipple Ointment Vol. 7 No. 6 430
Compounding for Investigational Studies: The Experience of Ken Hughes, RPh Vol. 7 No. 6 436
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Vol. 7 No. 6 441
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Vol. 7 No. 6 449
A Foot in the Door: Marketing Tips Vol. 7 No. 6 454
Technology Spotlight: Automated Prescription-Dispensing Systems Vol. 7 No. 6 458
Basics of Compounding for Dry-Skin Conditions Vol. 7 No. 6 460
Wool Alcohols Ointment Vol. 7 No. 6 462
Water-Absorbing Ointment Vol. 7 No. 6 462
Natural Emollient Oil Vol. 7 No. 6 462
Emulsion Base to be Individualized Vol. 7 No. 6 462
Premixed Oil Phase for Preparing Oil-in-Water (O/W) Emulsions Vol. 7 No. 6 463
O/W Emulsion Vol. 7 No. 6 463
Lotion with Cyclomethicone Vol. 7 No. 6 463
Water-Repelling Lip-Balm Stick Vol. 7 No. 6 463
Lip-Balm Stick (Basic Formula for Individualizing) Vol. 7 No. 6 463
Water-Repelling Lip Ointment Vol. 7 No. 6 463
Lip Ointment (Basic Ointment for Individualizing) Vol. 7 No. 6 463
Storage of Bulk Chemicals and Finished Preparations Vol. 7 No. 6 464
Calculations Vol. 7 No. 6 466
Bacitracin 500-U/g Ophthalmic Ointment Vol. 7 No. 6 467
Chloramphenicol 0.5% Ophthalmic Solution Vol. 7 No. 6 468
Clotrimazole 500-mg Vaginal Suppositories Vol. 7 No. 6 469
Ergoloid Mesylate 1-mg/mL Oral Liquid Vol. 7 No. 6 470
Meclocycline Sulfosalicylate 1% Cream Vol. 7 No. 6 471
Methadone HCl 2.5-mg Capsules Vol. 7 No. 6 472
Perphenazine 2.5-mg/5-mL Syrup Vol. 7 No. 6 473
Sulfasalazine 250-mg/5-mL Oral Liquid Vol. 7 No. 6 474
Tramadol HCl 100-mg Capsules Vol. 7 No. 6 475
Triprolidine HCl 2.5-mg Capsules Vol. 7 No. 6 476
Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids Vol. 7 No. 6 477
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Vol. 7 No. 6 481
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Vol. 7 No. 6 485
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations Vol. 7 No. 6 490
PostScription: Changing Pharmacy Regulations Could Affect US Compounders Vol. 7 No. 6 495
Home |  About  |  Contact  |  Advertising |  Privacy Policy                                                            ©2019 IJPC, Inc.